Since this medicine is usually administered by a qualified healthcare professional in the clinical/hospital setting, the likelihood of a missed dose is very low.
Since this medicine is administered in the hospital setting by a qualified healthcare professional, the likelihood of an overdose is very less. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.
Atracurium (moderate)
Raltegravir (moderate)
Nifedipine (moderate)
Cisatracurium (moderate)
This medicine is used to correct the magnesium levels in patients with low magnesium levels in the body when the patient is not able to tolerate oral supplements.
This medicine is used for the prevention and control of seizures associated with pre-eclampsia (a pregnancy complication characterized by increased blood pressure and protein in the urine) and eclampsia (a condition where there is an occurrence of seizures in pregnant women with severe preeclampsia).
This medicine is used for the treatment of patients with atrial tachycardia, a type of heart rhythm abnormality characterized by a constant rate of more than 100 beats per minute.
This medicine is used for the control of seizures.
Difficulty in breathing
Swelling of eyelids, face, lips
Itching and rash
Dizziness and Drowsiness
Pain at the injection site
Muscle weakness
Excessive thirst
Slurred speech
This medicine is not recommended for use in patients with a known allergy to Mag-S Injection 10 Ampx2 mL or any other inactive ingredients present in the formulation.
This medicine is not recommended for use in patients with hypermagnesemia (high blood magnesium levels) due to the increased risk of adverse effects.
This medicine is not recommended for use in patients with hypercalcemia (high levels of calcium in the blood) due to the risk of worsening of the patient's condition.
This medicine is not recommended for use in patients with myocardial damage due to the risk of worsening of the patient's condition.
This medicine is not recommended for use in patients with diabetic coma due to the risk of worsening of the patient's condition.